qXR-CTR vs Mindbowser AI Cardiovascular Risk Prediction

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Qure.ai
VS

AI Verdict

qXR-CTR is an AI-powered tool specifically designed for automated cardiothoracic ratio measurement from chest X-rays, aiding in the assessment of heart size and potential heart failure risk. In contrast, Mindbowser AI Cardiovascular Risk Prediction offers a broader, data-driven approach to assess overall cardiovascular risks, integrating with EHR systems for comprehensive patient data analysis. Therefore, qXR-CTR is suited for radiology-focused diagnostic support, while Mindbowser's tool provides a wider clinical decision support system based on diverse patient data.

Choose qXR-CTR if…

Choose qXR-CTR if your primary need is automated, rapid, and objective measurement of the cardiothoracic ratio directly from chest X-ray images. This tool is ideal for radiology departments or emergency settings requiring quick assessment of heart size to screen for potential heart failure risk, streamlining image interpretation workflows.

View qXR-CTR →

Choose Mindbowser AI Cardiovascular Risk Prediction if…

Choose Mindbowser AI Cardiovascular Risk Prediction if you require a comprehensive, integrated solution for assessing a patient's overall cardiovascular risk across various data points, not just imaging. This tool is best suited for healthcare providers and hospitals seeking to integrate AI-powered risk prediction directly into their EHR systems for clinical decision support, proactive patient management, and personalized care planning.

View Mindbowser AI Cardiovascular Risk Prediction →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature qXR-CTR Mindbowser AI Cardiovascular Risk Prediction
Pricing Unknown Contact for pricing
Deployment Can be deployed on cloud or on-premise. The Qure.ai app receives DICOM studies via DICOM network protocol from medical systems (PACS/Modality) or can import DICOM from the local system. The received DICOM study is processed in Qure's cloud server, and AI-processed reports are displayed on the app. Cloud-based
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Unknown
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Mindbowser AI Cardiovascular Risk Prediction

While Tool A offers a focused, automated task, Tool B emphasizes seamless integration with major EHR systems (Epic, Cerner, Athenahealth, FHIR) and offers a Clinical Decision Support System. This deep integration into existing clinical workflows significantly enhances usability for healthcare providers by reducing friction and centralizing information, despite potentially a more complex initial setup.

Clinical Value

qXR-CTR

Tool A (qXR-CTR) has explicit FDA clearance, indicating a higher level of regulatory validation and demonstrated clinical efficacy for its specific function of automating cardiothoracic ratio (CTR) measurement to assess heart size and potential heart failure risk. While Tool B aims to assess cardiovascular risks and offers clinical decision support, the provided information does not explicitly state FDA clearance or comparable regulatory validation for its risk prediction capabilities.

Pricing & Value

Tie

Both tools require direct contact for pricing information, with no publicly disclosed details available. This lack of transparency makes it impossible to conduct a head-to-head comparison of their cost-effectiveness or overall value.

Enterprise Readiness

Mindbowser AI Cardiovascular Risk Prediction

Tool B demonstrates superior enterprise readiness through its explicit mention of SOC 2 compliance and robust integration capabilities with major EHR systems like Epic, Cerner, and Athenahealth, alongside HL7 and FHIR interoperability. While Tool A offers flexible deployment options, Tool B's detailed integration features and additional compliance are critical for seamless adoption within complex healthcare IT environments.

Innovation

Mindbowser AI Cardiovascular Risk Prediction

Tool B appears more innovative by offering a comprehensive AI-powered cardiovascular risk prediction system integrated into clinical decision support, coupled with extensive data analytics and broad interoperability. Tool A, while valuable, focuses on automating a specific measurement from X-rays, which represents a more incremental application of AI compared to Tool B's holistic approach to risk assessment and decision support.

Support & Docs

qXR-CTR

Qure.ai (Tool A) provides structured support channels, including a dedicated HelpCenter with app documentation, options to request support, report issues, and send ideas, along with assigning a dedicated client success partner and a stated response time for email queries. Mindbowser (Tool B), while offering custom solutions, does not publicly detail a comparable level of structured product support or documentation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature qXR-CTR Mindbowser AI Cardiovascular Risk Prediction
Tool Name qXR-CTR Mindbowser AI Cardiovascular Risk Prediction
Company Qure.ai Technologies Mindbowser
Description qXR-CTR is an AI-powered software by Qure.ai that automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. Mindbowser's AI Cardiovascular Risk Prediction tool is part of their comprehensive suite of healthcare AI solutions, designed for providers and hospitals to assess cardiovascular risks. It emphasizes compliance with HIPAA and SOC 2 and integrates with leading EHR systems.
Tagline AI-powered Chest X-ray Solution for Automated Cardiothoracic Ratio Assessment. We bridge technology & compassion to build smarter, compliant, patient-centered care.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI
Specialties Cardiology, Radiology Cardiology, Family Medicine, Internal Medicine
Key Features Not specified AI Cardiovascular Risk Prediction, AI-powered automation, HIPAA and SOC 2 compliance, EHR integration (Epic, Cerner, Athenahealth, FHIR), Clinical Decision Support System, Data & Analytics, HL7 & FHIR interoperability, Secure, compliant healthcare data access

Videos

Demos, reviews, and walkthroughs featuring qXR-CTR and Mindbowser AI Cardiovascular Risk Prediction.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

qXR-CTR specifically automates the measurement of the cardiothoracic ratio (CTR) from chest X-ray images, aiding in the assessment of heart size and potential heart failure risk. In contrast, Mindbowser AI Cardiovascular Risk Prediction offers a broader assessment of overall cardiovascular risks, leveraging AI to evaluate individual patient risk for cardiovascular conditions, often through EHR integration.
Mindbowser AI Cardiovascular Risk Prediction explicitly highlights robust EHR integration capabilities, including compatibility with Epic, Cerner, Athenahealth, and FHIR, along with HL7 & FHIR interoperability. The provided information for qXR-CTR does not specify its EHR integration capabilities, though it integrates into existing radiology workflows.
qXR-CTR is designed for use in Cardiology and Radiology specialties. Mindbowser AI Cardiovascular Risk Prediction targets a broader range of specialties, including Cardiology, Family Medicine, and Internal Medicine.
Both qXR-CTR and Mindbowser AI Cardiovascular Risk Prediction are HIPAA compliant and have a Business Associate Agreement (BAA). Mindbowser AI Cardiovascular Risk Prediction additionally emphasizes SOC 2 compliance.
AI Tool Finder
AI-powered search. Results may not be comprehensive.